Background: Transcranial direct current stimulation (tDCS) is investigated to modulate neuronal function 19 by applying a fixed low-intensity direct current to scalp. 20
Introduction 56
tDCS involves low-intensity direct currents (few mA) applied to the scalp via pad electrodes 57 (typically 25-35
2 ) [1] or smaller electrodes in arrays (HD tDCS; [2] ). Encouraged by the general safety 58 profile [3-5], low intensity tDCS has been broadly tested as a tool for cognitive research in healthy subjects 59
[6] as well as to treat a broad range of neurological and psychiatric disorders and symptoms [7, 8] . It is 60 generally accepted that the physics of tDCS dictates that current flow intensity in the brain (electric field) 61 will increase linearly with applied current (Figure 1) [9]. Rather, our primary question is whether 62 neurophysiological and behavioral responses also increase linearly, or at least monotonically, with applied 63 current intensity. Specifically, does increasing the current of tDCS (e.g. from 1 to 2 mA) increase effects 64 size for a given experiment and outcome measure? This question is relevant because any choice of 65 stimulation protocol and comparison among studies with different protocols rests on the ability to relate the 66 effects of one intensity to another in a rational way. 67
However, the question is complicated because the complete dose of tDCS is defined by the applied 68 current, the duration, and the electrode montage [10] which produce a complex pattern of current flow in 69 the brain; nonetheless, we focus here on the role of applied current intensity while noting how other factors 70 may influence (interact with) the current-intensity dose response. We discuss how individual anatomical 71 differences in the amount of current density (electric field) to the brain vary for the same applied current, 72 which may therefore lead to variations in individual intensity-response [11] . Moreover, we consider the 73 extent to which tDCS responses vary with brain-state, magnifying individual-and task specific variations 74 in dose-response. 75
In the last two decades, tDCS dose-response relationship has been evaluated from different 76 perspectives ranging from single cells, to small local brain circuits and synapses, to large networks, to 77 overall brain function and behavior. Assuming a causal chain across different scales (applied current first 78 changes single cells, which alter local and large networks, which change behavior), the lack of a linear 79 response at any of these scales may preclude an aggregate linear dose response at the behavioral level 80 ( Figure 1 ). The organization of this document centers around measurement approaches (e.g. animal models, 81 imaging) but specific techniques often map specific scales (Figure 1 ; e.g. animal models measures small 82 circuits, imaging measures large network). We discuss tDCS intensity dose response through these different 83 perspectives. 84
Basic biophysics of intensity-response 85
Modeling studies relate the applied dose to the scalp [10] , including current intensity, to the 86 resulting electric field (or current density) in the brain [12] . While current (in units of mA) is the controllable 87 stimulation parameter, electric field (in unit of V/m) reflects the local stimulation intensity each brain region 88 is actually exposed to. It is generally accepted that the physics of tDCS dictates that current flow intensity 89 in the brain (electric field) will increase linearly with applied current [9] . Therefore, the question is not if 90 there is a linear response between increasing applied current and brain electric field but rather if the brain 91 response to increasing electric field is itself linear. As noted above, in humans, the electric field varies with 92 individual anatomy (the implications of which are discussed below), though in any case it tracks linearly 93 for a given individual and scales across a population. In some animal models, notably in-vitro brain slices 94
[13], the electric field intensity can be tightly controlled allowing direct testing of electric field dose-95
response. 96
Modeling studies predict that for low intensity range of applied current (i.e. 2 mA), induced electric 97 field in the brain is less than 1 V/m ( Figure 1) [14]. These predictions have been directly [15] [16] [17] [18] and 98 indirectly validated [19, 20] . Because of these low electric fields, it has been suggested that the primary 99 effects of tDCS are due to changes in the membrane potentials of neurons with most attention paid to 100 pyramidal grey matter neurons orientated orthogonal to the brain surface [13, 21] or to synaptic terminals 101
[22]. In this view, any effects of tDCS are secondary to changes in this polarization [23, 24] . Even when 102 other cell types may be implicated (e.g. glia, [25], the primary mechanism of tDCS is speculated to act 103 through polarization of these cell membranes [26] . 104
Basic theory of tDCS suggests that membrane polarization would be polarity-specific and linear 105 with applied current intensity (i.e. generated electric field (EF)). This is because tDCS is low intensity (few 106 mA) and so considered to depend on subthreshold resting membrane potential changes rather than directly 107 inducing neuronal firing (e.g., 700-1000 mA used in ECT). Thus, assuming membrane polarization is the 108 key determinant for the effect of tDCS, it is reasonable to assume that increasing tDCS intensity will 109 increase effects size in general ( Figure 1 ). However, this may strictly only apply in well-controlled 110 preparations; in the brain, responses may be non-linear and occur in a complex (e.g. non-linear, 111 homeostatic) manner. Therefore, a critical unanswered question is whether increasing current in the tDCS 112 range applied in humans (4mA or less) enhances neuromodulation and outcomes in a linear, or at least 113 monotonic manner. This question of linear dose response for a given polarity can be distinct from whether 114 there are any polarity specific effects. Notably, if one considers folding of the cortex and diffuse current 115 flow, tDCS produces mixed polarity effects under each stimulation electrode [22, 27] . This again 116 emphasizes that extrapolation from well-controlled animal studies can be fraught with oversimplification. 117
Indications about intensity-response of tDCS from animal models 118
Quiescent neurons are those that are not spontaneously firing action potentials (which is an 119 anomalous state because neurons in vivo are active); such neurons can be observed in brain slices with 120 normal superfusate. Application of electric fields to such quiescent neurons suggest a linear correlation 121 between induced membrane polarization and electric field intensity polarity ( Figure 1 ) (i.e. the more 122 external electric field, the more neuronal polarization). However, this relationship has been thoroughly 123 tested only for intensities above those applicable to studies in humans (>10 V/m). Theoretical neuron polarization models based on traditional electrical stimulation theory predict a linear 133 polarization across all sub-threshold intensities in quiescent neurons including tDCS ranges of < 1 V/m 134
Membrane polarization is easiest to measure in quiescent neurons. However, neurons in vivo are 136 active, not quiescent. Any dose response assessment should therefore be conducted in firing (non-quiescent) 137
neurons. Assessing dose-response relationships is more complex in this case because: 1) the properties of 138 the neuronal membrane changes with ongoing activity [31, 32]; and 2) any targeted neuron is coupled with 139 a larger population or entire network and its activity is presumably mediated by changes in network activity 140 showed pathway and activity state-dependent plasticity modulation by DCS. Although these findings do 159 not in themselves indicate that the dose-response of any given activity is not monotonic, they show that the 160 response to a given dose can categorically vary on different outcome measures (e.g. brain states). While, 161 on the one hand, the ongoing activity in brain slices ("brain state") is abstracted from the in vivo case, on 162 the other hand, brain slices provide exquisite control and monitoring of brain state, supporting the testing 163 of hypothesis on the role of brain state in DCS intensity dose response. 164
In summary, in both quiescent and active neurons of animal brains there is (remarkably) no 165 comprehensive evidence for a linear dose-response relationship at electric field intensities below 1 V/m. 166
There is, however, evidence of neurophysiological changes at specific low intensities supporting that tDCS 167 can modulate brain function. Some dose response is expected in animal models (starting with no response 168 for a no-stimulation condition of 0 V/m) but the absence of clear escalation in response with intensities up 169 to 1 V/m (e.g. including 0.25 V/m, 0.5 V/m, 0.75 V/m, 1 V/m) is noteworthy and a critical area for future 170
studies. 171
We note that evidence for dose response from other neuromodulation approaches using supra-172 threshold (high intensity) pulse approaches such as deep brain stimulation (DBS) [37, 38] provide direct evidence in support of non-linear tDCS dose-response given the presumed unique mechanism 179 of action when using a DC waveform. Finally, to foreshadow the following section, animal studies are 180 anatomically constrained, and generally record from a very small section of cortex. Results from such 181 preparation may not easily transfer to applications in humans, which lead to a much larger extent of 182 stimulated cortex and thus are influenced by the complex interactions with the convoluted cortical structure. 183
Diffuse current flow in tDCS vs. HD-tDCS 184
Prior to expanding on dose-response data in humans, some comments on the relationship between 185 applied current and resulting brain current flow patterns are critical. While dose of tDCS is defined by 186 operator controlled factors including current intensity [10] , the electric field generated in the brain will vary 187 by individual and will fluctuate in space across the brain ( then how the different brain areas interact. As we discuss later, one approach to account for this complexity 201 is to use multiple tDCS montages along with models of current flow to regress dose-response in human 202
studies. 203
Since the spatial distribution of stimulation could impact dose response, a complimentary approach 204 to conventional tDCS is the use of smaller HD electrodes. HD-tDCS electrode arrangements include or maximize current to deep structures [47] . With the goal of understanding current intensity dose-response 209 by stimulating a relatively smaller and more controlled area of cortex, concentric-ring HD-tDCS is 210 especially a useful tool in addition to pad-based tDCS. However, direct comparisons are few [48] [49] [50] . 211
Indications about intensity-response of tDCS from human neurophysiology 212
In exploring dose response in humans, tDCS studies have relied heavily on MEP changes in 213 response to TMS to establish neurophysiological changes in motor regions by tDCS [4, 51] . In the most 214 basic experiments, the TMS-MEP threshold or MEP response to a fixed TMS intensity is measured before, 215 during and/or after application of tDCS. A linear dose response would predict that increasing intensity (i.e., 216 > mA) would proportionally increase the degree of modulation (i.e., > TMS-MEP). Indeed, early canonical 217 studies in healthy subjects used a low-dose range (up to 1 mA for several minutes) and initially suggested 218 a monotonic relationship between tDCS intensity and TMS-MEP size. 219
While several subsequent studies replicated the basic findings at 1 mA [52], a more complex dose 220 response has emerged. Increasing stimulation intensity, increasing duration (in cases by >10 minutes), 221 and/or concurrent brain activation or pharmacological manipulation [53] [54] [55] [56] [57] [58] can also change the extent and 222 direction of excitability changes measured by TMS-MEP and, so, the dose-response [59] . For example, 223 priming the motor region during "anodal" tDCS (asking subjects to activate hand muscles) can invert the 224 direction of TMS-MEP modulation suggesting that the direction is state dependent. Increasing "cathodal" 225 tDCS intensity to 2 mA can result in TMS-MEP enhancement [53] .Children also exhibited non-monotonic 226 dose-response but over a different intensity range. Indeed, as compared to adults [54] "cathodal" 227 stimulation became excitatory at only 1 mA. This difference in dose-response within children compared to 228 adults was consistent with altered brain electric field for small head sizes [60, 61]. 229
As noted above, most of the extant clinical neurophysiology research has used conventional pad 230 tDCS, where current may be delivered to diverse brain regions ( Figure 2 , A and B) [15, 17] . To the extent 231 that any given measured response is influenced by current from more than one region (e.g. TMS-MEP is 232 influenced by current not only from the motor area but also from premotor regions and afferent deep brain 233 structures), then dose response will be related to how increasing current to each of these regions in aggregate 234 influences TMS response. Therefore, an important question is if using HD-tDCS, where more nuanced 235 control of current flow is predicted, is useful in dissecting and clarifying dose response [62, 63] . 236
In summary, neurophysiological findings in humans indicate that tDCS outcomes are not 237 necessarily linear, nor even monotonic, with increasing tDCS intensity (even in the limited range of 1-2 238 mA). Moreover, the nature of modulation is profoundly influenced by variations in brain state. TMS-MEP 239 as a probe of brain function, represents a combination of complex measures itself influenced by several 240 physiological factors including the excitability of neuronal circuits at both cortical and spinal level [3] and 241 do not simply map to behavioral changes. In addition, TMS-MEP is typically measured after tDCS (i.e., 242 offline) and thus may not always reflect the response to concurrent tDCS (i.e., online) effects, which 243 presumably accumulate during the stimulation period (as reinforced by data on tDCS duration) [4, 64] . 244
Moreover, it is unclear whether non-motor cortex responds in a comparable manner following tDCS, which 245 has profound implications for cognitive neuroscience and neuro-rehabilitative efforts. More generally, the 246 notion that tDCS adjusts brain excitability and functions like a "sliding scale" (that is simply "measured" Hampstead and colleagues (2014) demonstrated polarity dependent BOLD signal change during task 261 performance [73] and resting-state connectivity [74] in healthy young participants such that these measures 262
were generally relatively enhanced with anodal stimulation but suppressed with cathodal stimulation. data directly correlating effect size in tDCS human trials with current intensity [53] . For instance, the 280 influence of current intensity (i.e. 1 mA, 2 mA) was investigated on a working memory task among healthy 281 controls, indicating a non-monotonic current intensity dose-response [85] . In another study, none of the 282 examined intensities (i.e. 1mA, 2 mA) produced significant effects in a working memory task [86]. Cuypers 283 and colleagues (2013) indicated a dose-response relationship in a motor learning task with significant 284 enhancement in motor performance at 1.5 mA but not 1 mA [56]. We note the important statistical caveat 285 that a significant response at one dose, but not another, does not itself establish a difference between two 286
doses. 287
Most behavioral and cognitive studies have used large pad-sponge electrodes. Thus, any given 288 response is influenced by stimulation of more than one cortical region, and dose-response is reflecting the 289 amalgamation of current flow across many regions with varied intensity in brain areas (see below; Figure  290 3). The use of HD-tDCS would significantly reduce current spread, but given current spread even under 291 optimized HD-tDCS is greater than one gyri which is the size of a typical ROI. Use of HD-tDCS reduces 292 but not remove this confound. 293 294
Indications about dose-response from functional outcomes in medically ill populations 295
While tDCS is widely investigated as potential therapeutic tool to enhance cognitive rehabilitation in 296 neuropsychiatric disorders [87, 88] , only a few studies explored dose-response and with a limited number 297 and range of dose. Protocol variations limit generalization across studies (e.g. electrode montages, cognitive show that conventional tDCS with large electrodes are placed "over" the target areas. In fact, they deliver 324 current to brain regions between the anode and the cathode (Figure 2, A and B) [2, 55]. This diffusivity and 325 lack of clear targeting complicates the analysis of response intensity and, at the same time, it reinforces that 326 computational models are needed to comprehensively investigate dose response. Using current flow 327 modeling, there have been: 1) Retrospective attempts to correlate electric field intensity in regions of 328 interest (ROI) with clinical outcomes using different montages (with fixed current), under the hypothesis 329 that montages that enhance electric fields in ROIs (for a given current) will enhance outcomes; 2) 330
Retrospective correlations of electric field intensity in ROIs with behavioral outcomes with a fixed montage 331 and fixed current considering how individual head anatomy differences affect brain current intensity, and 332
3) Prospective attempts to optimize the tDCS montage to deliver electric fields to ROIs, in some cases 333 accounting for individual anatomy, under the hypothesis that this would enhance outcomes compared to a 334 uniform tDCS montage [100]. 335
Using current flow modeling, retrospective efforts comparing montages have provided indirect 336 evidence that electric field intensity produced by tDCS in a ROI correlates with enhanced clinical (e.g. pain, 337 Participants who showed significant enhanced WM task performance (good responders) had significantly 341 higher electric field intensity over the DLPFC than other participants (bad responders), suggesting that 342 variability in behavioral outcomes of tDCS might be partly due to individual anatomical differences, 343 consistent with a monotonic dose response. 344
In some cases, current flow models have been used to optimize response to tDCS, but in these cases 345 an implicit assumption has been made about a local (tissue level) monotonic dose response, namely that 346 designing approaches that deliver more electric field to a given brain region will increase effect size. Several 347 attempts to individualize tDCS by using current flow models to optimize electric field to a target brain 348 [63], such HD approaches have yielded encouraging effect sizes, often larger than those using conventional 356 tDCS montages. However, these HD-tDCS montages typically reduce the spatial extent of current in the 357 brain rather than electric field intensity [47] and reinforce the role of the spatial distribution of current flow 358 in influencing dose response rather than providing support for a dose-response itself. 359
Methodology to systematically investigate dose-response 360
The thesis of this paper -that there is deficiency in the current knowledge on tDCS intensity dose 361 response -in turn indicates a need for expanded and more rigorous current intensity dose response testing 362
[106]. Approaches to experimental design of dose-response studies are discussed in this section (Figure 3) , 363 two in animal (in-vitro and in-vivo) and four in human trials (fixed current with conventional pad electrodes, 364 controlled electric field with conventional pad electrodes, fixed current with high-definition electrodes, and 365 controlled electric field with high definition electrodes). 366
Animal studies provide special opportunities to explore dose-response relationships, but only if 367 conducted in meaningful ways to the human stimulation [26] . In-vitro brain slice experiment uses an 368 escalation of electric field intensity (Figure 3 A.1) , which is more meaningful to control than applied 369 current. Using specific stimulation techniques (i.e. large parallel wires;[13]), with a uniform electric field 370 the entire tissue is exposed to a single magnitude and electric field direction (e.g. 1 V/m normal to the 371 cortical surface). An experimental measure from brain slices, which can be electrophysiological or 372 molecular, can then be related to the applied electric field as a proxy for local tissue response to escalating 373 electric field intensity. While some variability in response to a given electric field is expected in any 374 experimental system, brain slices offer the possibility for high-throughput experimentation yielding results 375 with high confidence. 376
In-vivo experiments involve non-invasive stimulation, under current control [26]. The animal 377
anatomy will determine the resulting electric field in the ROI, and varied electric field across other brain 378 regions which may influence outcomes (Figure 3 A. 2). Brain electric field distribution can be predicted 379 using current flow models [5, 107, 108] . For any given applied current, significant inter-species variation 380 and some inter-animal variation is expected in the resulting brain electric field. An experimental measure 381 from animals, which can span electrophysiological, molecular, or behavioral, is correlated with the applied 382 current. Variability in response across animals for a given dose, can be minimized through experimental 383
design. 384
In a conventional tDCS current intensity dose response experiments, two or more stimulation 385 currents (e.g. 1 mA and 2 mA) are applied across individuals using conventional sponge-pad electrodes 386 ( Figure B.2) . While straightforward from a design perspective, this approach has several methodological 387 caveats. Applying fixed current in a population lead to significant inter-individual differences in brain EF 388 that are a function of each subject's head anatomy [11] . Considering a relatively wide distribution of brain 389 EF in ROI, means that some subjects in the "low dose" (e.g. 1 mA) group may have a higher EF in the ROI 390 than some subjects in the "high dose" (e.g. 2 mA) group. The range of doses typically explored (e.g. 2x 391 from 1 mA to 2 mA) is less than the range of sensitivity across subjects (e.g. 3-5x across healthy adults 392
[44]). Use of a wider current range (if tolerated) mediates these overlaps, but does not mitigate the large 393 variance in effective brain current with this approach. 394
Still more problematic is that with conventional tDCS montages, electric field is generated across 395 wide regions of the brain, with the location of peak electric field varying across individuals, and often not 396
occurring "under" the electrodes [2]. These issues compound such that the average electric field in a none 397 ROI at the "low dose" can be higher than the electric field in the nominal ROI under high-dose. Ultimately, 398 using this simplistic current intensity dose-response experimental design (Figure 3 B.2) , one must interpret 399 the effects of tDCS, and so the dose response, as reflecting the amalgamation of current flow across many 400 regions with varied intensity. 401
The above concerns can only be partially mitigated by normalizing electric field intensity to the 402 ROI for each subject (Figure 3 B.1) . In a second experimental design for human trials, using individual 403 MRI and modeling the individualized current needed for each subject is determined to produce a consistent 404 electric field in a given ROI. Notably in this method each subject will receive a unique current for a given 405 target electric field (e.g. 0.5 V/m) in the ROI, and this current may vary several-fold variation in current 406 applied across individuals (e.g. 0.6 mA, 1.4 mA, 2.1 mA…) as a result of the aforementioned inter-407 individual anatomical differences [44] . Dose escalation therefore involved increased electric field in the 408 ROI (e.g. 0.5 V/m, 1 V/m) not applying a multiple to the individual applied current for each subject. An 409 experimental measure from the trial, which can span electrophysiological, imaging, or behavioral, is 410 correlated with the electric field in the ROI. Because conventional tDCS pads are still used, current can 411 flow through the brain with maximum electric field not necessarily in the ROI and not in a consistent 412 location across subjects [44] . To the extent that current flow to other brain regions influences the outcome 413 measure, it is a problem that the electric field intensity is not controlled outside the ROI. 414
An addition to the fixed-current approach (Figure 3 B. 2) is to retrospectively model individual 415 current flow and then correlate with experimental measure with the post-hoc calculated electric field in the 416 nominal ROI. This leads to a distribution of predicted electric fields with some subjects in the "low dose" 417 current group (e.g. 1 mA) presenting a higher electric field in the ROI than some subjects in the "high dose" 418 current group (e.g. 2 mA). This post-hoc modeling may not meaningfully mediate the concern with broad 419 and varied brain current flow across subjects using pad montages, as the relative electric field distribution 420 across individuals will vary. 421
Using High-Definition tDCS, and specifically the 4x1 montage, current is restricted to defined brain 422 regions (ROI within the electrode ring); the peak electric field is within this brain region and thus consistent 423 across subjects. In a third experimental design for human trials, a dose response trial design using 4x1 HD-424 tDCS and the fixed current escalation method (e.g. 1 mA, 2 mA) provides evidence at the population level 425 if increased intensity at the ROI is correlated with an outcome measure (Figure 3 C.2) . Focal EF produced 426 by HD montage provide a substrate for controlling impact of stimulating functional/structural connected 427 areas outside the ROI (Figure 3, C) . Thus, an essential difference from conventional pad-tDCS is that 428 electric fields outside the ROI are low enough that increasing applied current still does not result in 429 significant current outside the ROI. 430
In a fourth experimental design for human trials, using the 4x1 High-Definition tDCS montage, 431
individualized modeling based in subject-specific MRI can be used to normalize the electric field across 432 individuals (Figure 3 C.1 ). An experimental measure from the trial, which can span electrophysiological, 433 imaging, or behavioral, can be meaningfully correlated with the electric field in the ROI. It is possible 434 using the fixed current 4x1 High-Definition tDCS (Figure 3 In all four experimental noted designs for human trial, variability in response for a given dose (fixed 440 current or electric field controlled) is expected reflecting individual neurophysiological and brain state 441 differences, which may be mitigate through rigorous experimental design (e.g. subject inclusion criteria, 442 testing environment) but never eliminated. These physiological variations are compounded by any 443 limitations in dose-response design described above which further emphasizes the need for careful 444 consideration of dose-response experimental design. The four classifications described above by no means 445 fully characterizes the diversity of approaches and issues which must be considered for meaningful tDCS 446 (and hence between study) comparison prone to complication, and hampers non-spurious assessment about 454 the sources of tDCS response variability [114] . 455
The biophysics of tDCS, namely the fact that increasing current produces a linear increase in brain 456 electric field (Figure 1) [9] and, then, presumably membrane polarization [13] , is only a starting point and 457
it does not allow conclusions that increasing tDCS intensity enhances a given neurophysiological, intensities below 1 V/m). Studies using TMS-evoked potentials have also provided an extensive substrate 463 to design and understand tDCS protocols [59] , but challenges simple notions of linear dose-response of 464 tDCS in humans on a group or individual level [52, 53] . 465
Canonical neurophysiological studies tested intensities only up to 1 mA in the absence of tasks [4, 466 24] and suggested a simple polarity response consistent with classical animal studies. However, 467 increasingly higher intensities are adopted (2 or 1.5 mA; [95, 115, 116] and tDCS is typically used in 468 combination with training [117], where evidence suggest a multi-factorial dose response that is not 469 necessarily monotonic with current intensity nor does it follow a simple excitability-change rule 470 (anode/cathode, boost/suppress). Imaging studies support a complex response across brain regions. 471
Computational models are a tool to normalize brain current intensity across individuals but are themselves 472 subject to assumptions about local dose response (e.g. doubling local current intensity in a ROI increases 473 its response) to current that remains to be validated. 474
In conclusion, extant data on tDCS mechanisms are inconclusive in regards to whether or not 475
graded changes in applied current, and hence brain electric fields, enhance effect sizes in a linear or 476 monotonic way. Put simply, we still do not know whether more intensity of electric field in a given brain 477 area supports greater neurophysiological or behavioral outcomes [114] . We believe that this is a crucial 478 point given extensive ongoing research on tDCS. Noting the heterogeneity of the literature on tDCS dose-479 response [118], we urgently need to understand how much current we should deliver and how different 480 brain regions will respond. We suggest rigorous efforts to quantify dose-response in humans, regardless of 481 approach and outcome measure, will benefit from including computational current flow models. Despite 482 these conclusions, we emphasize that uncertainty about dose-response does not necessarily diminish the 483 impact of exhaustive testing of tDCS effects, its potential utility, or the value of an extensive mechanistic 484 analysis that already exists on tDCS. behavior and task performance. Induced electric field (or current intensity) in the brain increases linearly with applied 811 stimulation current. In well-controlled, in-vitro experiments, increased membrane polarization can be reasonably 812 assumed with increasing tDCS intensity but in an active brain, nonlinear and complex behavior is more likely.
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Different experimental, modeling and imaging techniques assist to map tDCS modulation in specific scales. an epi-cranial electrode which results is animal-specific electric field in the ROI (red) and varied electric fields in 837 other brain regions (Yellow, Black). Increasing the applied current increases all the electric field in each brain region 838 proportionally. Electric field in animal models will be dramatically above the human case when comparable currents 839 are applied. An outcome measures is recorded at varied applied current levels. (B.1) Using conventional electrode 840 pads, controlled electric field intensity can be applied to a ROI in human trials by varying the applied current in each 841 individual to generate a fixed electric field at the ROI. They require individual current flow modeling. The electric 842 fields in other brain regions are not controlled and so vary across individuals and may be higher than in the ROI. An 843 outcome measures is recorded at varied controlled ROI electric fields. (B.2) Using conventional electrode pads, a 844 fixed current is applied across subjects for each dose, which results in variable electric field at the ROI as well as at 845 other brain regions. For each subject, increasing the applied current increases all the electric field in each brain region 846 proportionally. The electric field may be maximal outside the ROI. An outcome measures is recorded at varied applied 847 current. [shaded inset] Post-hoc individual model may be used to reanalyze data based on predicted electric field in 848 the ROI. This may result in some subjects in the lower-current group having a higher electric field at the ROI than 849 some subjects in the low current group. (C.1) Using the high-definition 4x1 montage, controlled intensity electric field 850 can be applied to a ROI in human trials by varying the applied current in each individual to generate a fixed electric 851 field at the ROI. The require individual current flow modeling based on MRI. Across individuals, the electric field is 852 predicted to be focal and maximal at the ROI across stimulation intensities. An outcome measures is recorded at varied 853 controlled ROI electric fields. (B.2) Using the high-definition 4x1 montage, fixed currents are applied across, which 854 results in variable electric field at the ROI at each current, however, the maximal electric field remains in the ROI 855 across individuals. For each subject, increasing the applied current increases all the electric field in each brain region 856 proportionally, but the electric field remains minimal outside the ROI. An outcome measures is recorded at varied 857 applied current. [shaded inset] Post-hoc individual model may be used to reanalyze data based on predicted electric 858 field in the ROI. This may result in some subjects in the lower-current group having a higher electric field at the ROI 859 than some subjects in the low current group. 860 861 862 -To what extent can (canonical) findings on dose-response in the resting brain support response during a behavioral task, where specific brain regions are activated therefore changing their susceptibility to stimulation? -To what extent could non-monotonic dose response, which is dependent on individual anatomy and subject to interactions with brain state (e.g. task engagement), lead to false-negatives?
The limited work on tDCS dose response had typically applied a straightforward model to measure a response with increased tDCS intensity (e.g. from 1 to 2 mA).
-To what extent is this approach subject to assumptions about the spatial extent of current flow? -Could not accounting for inter-individual anatomical variability in such cases lead to falsenegatives?
-Could inter-individual variations in the intensity of current delivered to the brain combined with a non-monotonic response of the brain lead to false-negatives? -How can the assumptions, implicit in conventional dose-testing studies, be made more explicit?
-In dose response studies, can computational models be used to retrospectively predict brain current intensity across individuals for a fixed applied current? -Can the above retrospectively and prospective use of computational models reduce variability and/or increase effect size in tDCS efficacy trials? 864 865
